Skip to content

Organon OGN Debt-to-assets

Debt-to-assets at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Amgen logo
AmgenAMGN
0.6×0.0×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
0.2×0.0×
Biogen logo
BiogenBIIB
0.2×0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
0.7×+0.1×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's debt-to-assets?
Organon (OGN) reported debt-to-assets of 0.7× in Q1 2026.
How has Organon's debt-to-assets changed year-over-year?
Organon's debt-to-assets decreased by 3.1% year-over-year, from 0.7× to 0.7×.
What is the long-term trend for Organon's debt-to-assets?
Over 5 years (2020 to 2025), Organon's debt-to-assets has grown at a 194.3% compound annual growth rate (CAGR), from 0× to 0.7×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.